6 | Biological ProductsIBA
12/2020
-
12/2004 |
6 | AcidsIBA
04/2018
-
12/2004 |
5 | Peptides (Polypeptides)IBA
07/2019
-
03/2017 |
4 | Radioisotopes (Radionuclides)IBA
10/2022
-
12/2004 |
4 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
05/2021
-
01/2017 |
3 | RadiopharmaceuticalsIBA
12/2020
-
12/2004 |
3 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
12/2019
-
03/2017 |
3 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
10/2019
-
07/2018 |
3 | NGR peptideIBA
07/2019
-
01/2018 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017
-
11/2014 |
3 | Bevacizumab (Avastin)FDA Link
05/2017
-
11/2014 |
2 | Chelating AgentsIBA
05/2021
-
07/2018 |
2 | LigandsIBA
12/2019
-
01/2018 |
2 | IntegrinsIBA
10/2019
-
03/2017 |
2 | ribosomal protein S30IBA
07/2018
-
01/2017 |
2 | Folic Acid (Vitamin M)FDA LinkGeneric
01/2017
-
10/2016 |
2 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2016
-
11/2014 |
2 | PorphyrinsIBA
11/2013
-
07/2010 |
1 | SolventsIBA
10/2022 |
1 | Calcium-45IBA
10/2022 |
1 | NitroimidazolesIBA
05/2021 |
1 | azomycinIBA
05/2021 |
1 | cupric chloride (copper(II) chloride)FDA Link
12/2020 |
1 | gallium 68 PSMA-11IBA
12/2019 |
1 | Rituximab (Mabthera)FDA Link
10/2019 |
1 | arginyl-glycyl-aspartic acidIBA
10/2019 |
1 | cyclic arginine-glycine-aspartic acid peptideIBA
05/2019 |
1 | Arginine (L-Arginine)FDA Link
05/2019 |
1 | Aspartic Acid (Aspartate)FDA Link
05/2019 |
1 | Glycine (Aminoacetic Acid)FDA LinkGeneric
05/2019 |
1 | 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA
01/2019 |
1 | ubiquicidin 31-38IBA
07/2018 |
1 | Gallium-68IBA
07/2018 |
1 | CarbonIBA
04/2018 |
1 | glycyl-glycyl-glycine (triglycine)IBA
04/2018 |
1 | AmidesIBA
04/2018 |
1 | asparagine-glycine-arginineIBA
01/2018 |
1 | samarium Sm-153 lexidronam (Quadramet)FDA Link
01/2018 |
1 | CD13 Antigens (Alanine Aminopeptidase)IBA
01/2018 |
1 | SamariumIBA
01/2018 |
1 | cyclo(aspargyl-glycyl-arginyl)IBA
01/2018 |
1 | Somatostatin Receptors (Somatostatin Receptor)IBA
12/2017 |
1 | Tyrosine Kinase InhibitorsIBA
10/2017 |
1 | Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2017 |
1 | 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA
05/2017 |
1 | ethylenediamine (ethylenediamine dihydroiodide)FDA Link
03/2017 |
1 | Pharmaceutical PreparationsIBA
01/2017 |
1 | ferric oxide (iron oxide)IBA
01/2017 |
1 | Liposomes (Liposome)IBA
01/2017 |
1 | SuspensionsIBA
01/2017 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2017 |
1 | Dextrans (Dextran)FDA Link
01/2017 |
1 | Cetuximab (Erbitux)FDA Link
01/2016 |
1 | Monoclonal AntibodiesIBA
01/2016 |
1 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2015 |
1 | Octreotide (Sandostatin)FDA LinkGeneric
04/2015 |
1 | perfluorosulfonic acid (Nafion)IBA
06/2014 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2013 |
1 | Progesterone Receptors (Progesterone Receptor)IBA
11/2010 |
1 | ProgesteroneFDA LinkGeneric
11/2010 |
1 | Ethiodized Oil (Ethiodol)FDA Link
10/2010 |
1 | Oxyquinoline (8 Hydroxyquinoline)FDA Link
10/2010 |
1 | Freund's AdjuvantIBA
06/2009 |
1 | MetalsIBA
09/2008 |
1 | 177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA
09/2008 |
1 | IonsIBA
09/2008 |
1 | lauric acid (dodecanoic acid)IBA
04/2007 |
1 | ferriteIBA
04/2007 |
1 | Alanine Transaminase (SGPT)IBA
04/2007 |